We have located links that may give you full text access.
Journal Article
Review
The Diagnostic Performance of Serum αvβ6 Autoantibodies for Ulcerative Colitis: A Systematic Review and Meta-Analysis.
Clinics and Research in Hepatology and Gastroenterology 2024 March 17
BACKGROUND AND OBJECTIVE: Currently, there is no single golden standard for diagnosing ulcerative colitis (UC). Now serum αvβ6 autoantibodies have shown promise as a diagnostic tool for UC. Here the aim was to determine the diagnostic performance of serum αvβ6 autoantibodies for UC.
METHODS: PubMed, the Cochrane Library, the Embase, and the Web of Science were searched comprehensively. STATA software was utilized to analyze the relevant data.
RESULTS: 9 studies from 6 articles with 1827 subjects were eligible. The summary sensitivity and specificity of serum αvβ6 autoantibodies to diagnose UC were 0.82 (95% confidence interval (CI): 0.65-0.92) and 0.94 (95% CI: 0.90-0.97) with an area under the summary receiver operating characteristic curve of 0.96 (95% CI: 0.94-0.97). Subgroup analysis was conducted owning to substantial heterogeneity between studies (I2 = 97% and P < 0.001). The aggregate sensitivity and specificity to diagnose UC in adults were 0.75 (95% CI: 0.61-0.86) and 0.95 (95% CI: 0.90-0.97), and when using a threshold of mean control+3SD, 0.80 (95% CI: 0.60-0.91) and 0.96 (95% CI: 0.90-0.99), respectively. Additionally, to differentiate UC from healthy participants, non-inflammatory bowel disease, and Crohn's disease, the overall specificity was 0.96, 0.88, and 0.80, respectively.
CONCLUSIONS: serum αvβ6 autoantibodies, as a non-invasive tool, demonstrated good diagnostic accuracy for UC. However, their application may be limited in some immune-related disorders, and further studies are needed for validation.
METHODS: PubMed, the Cochrane Library, the Embase, and the Web of Science were searched comprehensively. STATA software was utilized to analyze the relevant data.
RESULTS: 9 studies from 6 articles with 1827 subjects were eligible. The summary sensitivity and specificity of serum αvβ6 autoantibodies to diagnose UC were 0.82 (95% confidence interval (CI): 0.65-0.92) and 0.94 (95% CI: 0.90-0.97) with an area under the summary receiver operating characteristic curve of 0.96 (95% CI: 0.94-0.97). Subgroup analysis was conducted owning to substantial heterogeneity between studies (I2 = 97% and P < 0.001). The aggregate sensitivity and specificity to diagnose UC in adults were 0.75 (95% CI: 0.61-0.86) and 0.95 (95% CI: 0.90-0.97), and when using a threshold of mean control+3SD, 0.80 (95% CI: 0.60-0.91) and 0.96 (95% CI: 0.90-0.99), respectively. Additionally, to differentiate UC from healthy participants, non-inflammatory bowel disease, and Crohn's disease, the overall specificity was 0.96, 0.88, and 0.80, respectively.
CONCLUSIONS: serum αvβ6 autoantibodies, as a non-invasive tool, demonstrated good diagnostic accuracy for UC. However, their application may be limited in some immune-related disorders, and further studies are needed for validation.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app